(1 - 9 von 10
)
DIAMICOM - Exzellente Ausbildung von Nachwuchs für die ...
www.diabsite.de
Sanofi wird vertreten durch PD Dr. rer. nat. Aimo Kannt und Dr. Ing. Paulus Wohlfart. Als neuer Pharma-Partner hat sich Sulfateq - eine Ausgründung Groninger Wissenschaftler - angeboten, der unter anderem wichtige Aufgaben im Bereich des Pharma-Mentoring übernimmt.
Drug Development – What is Hot & Not? - Danish Diabetes Academyddeacademy.dk › events
ddeacademy.dk
Head of Drug Discovery Aimo Kannt, Fraunhofer IME_TMP (DE) Director Jim Trevaskis, Giled Sciences (US) Former Senior Director David Parkes, ...
Friday14:15 Uhr: Therapie der Adipositas, des Diabetes...
www.lifescience.net
(Dr. phil. nat. Aimo Kannt (Sanofi), Medizinische Fakultät Mannheim der Universität Heidelberg) (DE). None | Posted on Feb 10, Recommendations: n/a.
The International Rare Disease ShowcaseEATRIS
eatris.eu
... and tips for the journey to the clinic – Anton Ussi, EATRIS, Dunja Huijbers. EATRIS, Aimo Kannt, ITMP, Martin de Kort, EATRIS, Toni Andreu, EATRIS ...
CILcare Welcomes Experts in Auditory ScienceHearing Review
hearingreview.com
— researchers in the hearing field to its Scientific Advisory Board (SAB): Keith Darrow, Stéphane Maison, Aimo Kannt, and Dona Jayakody.
CILcare expands its Scientific Advisory Board to accelerate ...MassBio
www.massbio.org
— Aimo Kannt led metabolic and cardiovascular disease research projects for almost twenty years at Sanofi. Dr. Dona Jayakody, Researcher and ...
Goethe Business School: #gbsnews #gbsmasterprogramswww.goethe-business-school.de › gbsnews
www.goethe-business-school.de
· Hack your brain at the Virtual MBA Experience; Welcome! New Pharma MBA faculty member Dr. Aimo Kannt. #gbsnews ...
Proxidrugs: a new tool to fight pathogens? - Labiotech.euwww.labiotech.eu › News and Trends
www.labiotech.eu
· Aimo Kannt, head of drug discovery and preclinical research at Fraunhofer ITMP in Frankfurt, is currently researching the new class of drugs ...
Proxidrugs in the fight against pathogenic proteinsMedical Xpress
medicalxpress.com
— Aimo Kannt, head of drug discovery and preclinical research at Fraunhofer ITMP in Frankfurt, is currently researching a new class of drugs with ...
sortiert nach Relevanz / Datum